Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
Blinatumomab
Blinatumomab
Brand names: Blincyto
| Form | Strength |
|---|---|
| SOLUTION, INTRAVENOUS | 35 mcg (1 ea) |
Last updated: Feb. 27, 2021
- Black Box Warning: Cytokine Release Syndrome and Neurological Toxicities
- REMS: Blincyto Kit
Safe Administration and Handling of Chemotherapy: See Policy 906.4802
Chemotherapy Preparation:
Preparation, Handling, Labeling, Dispensing and Disposal of Cytotoxic Drugs: Policy 916.4415
LH Pharmacy Services Chemotherapy Standards